Skip to main content

Table 4 Circulating levels of inflammatory mediators according to self-perceived fatigue and muscle endurance

From: The relationship between self-perceived fatigue, muscle endurance, and circulating markers of inflammation in participants of the Copenhagen aging and Midlife Biobank (CAMB)

Parameter

HIGH Fatigue

LOW Muscle

Endurance

NORMAL Fatigue

NORMAL Muscle

Endurance

HIGH Fatigue

NORMAL Muscle

Endurance

NORMAL Fatigue

LOW Muscle

Endurance

p-value*

General Fatigue

n = 119

n = 431

n = 225

n = 154

 

Log hsCRP (pg/mL)

0.213 ± 0.42a

0.015 ± 0.022b

0.040 ± 0.030b

0.008 ± 0.036b

< 0.001

Log IL-6 (pg/mL)

0.348 ± 0.032a

0.193 ± 0.017b

0.280 ± 0.023a

0.260 ± 0.032

< 0.001

Log TNF-α (pg/mL)

0.695 ± 0.018

0.654 ± 0.009

0.667 ± 0.013

0.685 ± 0.016

0.137

Log IL-10 (pg/mL)

0.156 ± 0.057

0.064 ± 0.030

0.068 ± 0.042

0.214 ± 0.05

0.043

Log IFN-γ (pg/mL)

-0.346 ± 0.036

-0.389 ± 0.019

-0.320 ± 0.026

-0.396 ± 0.036

0.130

Physical Fatigue

n = 102

n = 454

n = 202

n = 171

 

Log hsCRP (pg/mL)

0.184 ± 0.046a

-0.016 ± 0.021b

0.109 ± 0.032a

0.049 ± 0.034

< 0.001

Log IL-6 (pg/mL)

0.353 ± 0.035a

0.191 ± 0.016b

0.293 ± 0.025a

0.268 ± 0.026

< 0.001

Log TNF-α (pg/mL)

0.688 ± 0.020

0.649 ± 0.009

0.679 ± 0.014

0.690 ± 0.020

0.046

Log IL-10 (pg/mL)

0.160 ± 0.063

0.091 ± 0.030

0.009 ± 0.044

0.204 ± 0.047c

0.018

Log IFN-γ (pg/mL)

-0.364 ± 0.040

-0.387 ± 0.019

-0.317 ± 0.028

-0.379 ± 0.030

0.220

Reduced Activity

n = 113

n = 438

n = 218

n = 160

 

Log hsCRP (pg/mL)

0.182 ± 0.043a

-0.015 ± 0.021b

0.100 ± 0.031a

0.039 ± 0.035

< 0.001

Log IL-6 (pg/mL)

0.363 ± 0.033a

0.184 ± 0.016b

0.300 ± 0.024a

0.254 ± 0.027

< 0.001

Log TNF-α (pg/mL)

0.709 ± 0.018a

0.641 ± 0.009b

0.694 ± 0.013a

0.677 ± 0.015

0.001

Log IL-10 (pg/mL)

0.207 ± 0.059

0.050 ± 0.030

0.097 ± 0.043

0.178 ± 0.049

0.037

Log IFN-γ (pg/mL)

-0.347 ± 0.037

-0.381 ± 0.019

-0.334 ± 0.027

-0.393 ± 0.031

0.388

Reduced Motivation

n = 121

n = 436

n = 220

n = 152

 

Log hsCRP (pg/mL)

0.159 ± 0.041a

-0.008 ± 0.022b

0.085 ± 0.031

0.047 ± 0.037

0.002

Log IL-6 (pg/mL)

0.316 ± 0.031a

0.186 ± 0.017b

0.296 ± 0.023a

0.284 ± 0.028a

< 0.001

Log TNF-α (pg/mL)

0.696 ± 0.018

0.650 ± 0.009

0.677 ± 0.013

0.684 ± 0.016

0.052

Log IL-10 (pg/mL)

0.194 ± 0.057

0.038 ± 0.030

0.119 ± 0.042

0.187 ± 0.051

0.019

Log IFN-γ (pg/mL)

-0.341 ± 0.036

-0.384 ± 0.019

-0.329 ± 0.027

-0.401 ± 0.032

0.228

Mental Fatigue

n = 104

n = 467

n = 189

n = 168

 

Log hsCRP (pg/mL)

0.190 ± 0.044a

-0.001 ± 0.021b

0.083 ± 0.033

0.038 ± 0.035b

0.001

Log IL-6 (pg/mL)

0.263 ± 0.034

0.189 ± 0.016

0.307 ± 0.025a

0.318 ± 0.027a

< 0.001

Log TNF-α (pg/mL)

0.685 ± 0.019

0.649 ± 0.009

0.684 ± 0.014

0.691 ± 0.015

0.031

Log IL-10 (pg/mL)

0.141 ± 0.061

0.032 ± 0.029

0.150 ± 0.046

0.216 ± 0.048a

0.005

Log IFN-γ (pg/mL)

-0.383 ± 0.039

-0.382 ± 0.018

-0.324 ± 0.029

-0.369 ± 0.030

0.373

  1. ANCOVA analysis (with weekly physical activity, percentage body fat and presence of inflammatory conditions as covariates); values are expressed as adjusted mean ± SE; asignificantly different from participants with NORMAL Fatigue & NORMAL Muscle Endurance (Bonferroni post hoc test p < 0.05); bsignificantly different from participants with HIGH Fatigue & LOW Muscle Endurance. (Bonferroni post hoc test p < 0.05); csignificantly different from participants with HIGH Fatigue & NORMAL Muscle Endurance (Bonferroni post hoc test p < 0.05)